Category:Daniel Griffith Anderson of Framingham MA (US)

Daniel Griffith Anderson of Framingham MA (US)

Executive Summary

Daniel Griffith Anderson of Framingham MA (US) is an inventor who has filed 2 patents. Their primary areas of innovation include PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms (2 patents), PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms (2 patents), HETEROCYCLIC COMPOUNDS (macromolecular compounds (2 patents), and they have worked with companies such as Massachusetts Institute of Technology (2 patents). Their most frequent collaborators include (2 collaborations), (2 collaborations), (1 collaborations).

Patent Filing Activity

Technology Areas

List of Technology Areas

• A61K9/1272 (PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms): 2 patents
• A61K31/7105 (PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms): 2 patents
• C07D295/13 (HETEROCYCLIC COMPOUNDS (macromolecular compounds): 2 patents
• A61K47/543 ({Lipids, e.g. triglycerides; Polyamines, e.g. spermine or spermidine}): 1 patents
• A61K47/545 (PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms): 1 patents
• A61K47/548 ({Phosphates or phosphonates, e.g. bone-seeking (phospholipids): 1 patents
• A61K47/554 ({the modifying agent being a steroid plant sterol, glycyrrhetic acid, enoxolone or bile acid}): 1 patents
• A61K48/0033 (Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy): 1 patents
• C07C233/47 (ACYCLIC OR CARBOCYCLIC COMPOUNDS): 1 patents
• C07D211/14 (HETEROCYCLIC COMPOUNDS (macromolecular compounds): 1 patents
• C07D231/12 (HETEROCYCLIC COMPOUNDS (macromolecular compounds): 1 patents
• C07D233/61 (HETEROCYCLIC COMPOUNDS (macromolecular compounds): 1 patents
• C07D243/08 (HETEROCYCLIC COMPOUNDS (macromolecular compounds): 1 patents
• C12N15/113 (Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; {Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing (when used in plants): 1 patents
• C12N2310/11 (MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA (microbiological testing media): 1 patents
• C12N2310/14 (MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA (microbiological testing media): 1 patents
• C12N2310/141 (MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA (microbiological testing media): 1 patents
• C12N2310/531 (MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA (microbiological testing media): 1 patents
• A61K9/0075 (Medicinal preparations characterised by special physical form {(nuclear magnetic resonance contrast preparations or magnetic resonance imaging contrast preparations): 1 patents
• A61K9/1623 (PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms): 1 patents
• A61K9/5123 (PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms): 1 patents
• A61K31/711 (PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms): 1 patents
• C07C229/12 (ACYCLIC OR CARBOCYCLIC COMPOUNDS): 1 patents
• C07C229/16 (ACYCLIC OR CARBOCYCLIC COMPOUNDS): 1 patents
• C07D207/06 (HETEROCYCLIC COMPOUNDS (macromolecular compounds): 1 patents
• C07D213/38 (HETEROCYCLIC COMPOUNDS (macromolecular compounds): 1 patents
• C07D255/02 (HETEROCYCLIC COMPOUNDS (macromolecular compounds): 1 patents
• C12N15/88 (MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA (microbiological testing media): 1 patents

Companies

List of Companies

• Massachusetts Institute of Technology: 2 patents

Collaborators

• Bowen Li of Malden MA (US) (2 collaborations)
• Akiva Gordon of Somerville MA (US) (2 collaborations)
• Idris Raji of Boston MA (US) (1 collaborations)
• Luke Hyunsik Rhym of Cambridge MA (US) (1 collaborations)
• Manan Rajith Singh of Arlington MA (US) (1 collaborations)
• Jacob Witten of Cambridge MA (US) (1 collaborations)